nodes	percent_of_prediction	percent_of_DWPC	metapath
Saquinavir—ABCB1—peripheral nervous system neoplasm	0.195	1	CbGaD
Saquinavir—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0398	0.0707	CbGbCtD
Saquinavir—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0384	0.0683	CbGbCtD
Saquinavir—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0288	0.0512	CbGbCtD
Saquinavir—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0266	0.0473	CbGbCtD
Saquinavir—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0264	0.0469	CbGbCtD
Saquinavir—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0264	0.0469	CbGbCtD
Saquinavir—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0245	0.0436	CbGbCtD
Saquinavir—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0225	0.0399	CbGbCtD
Saquinavir—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0198	0.0352	CbGbCtD
Saquinavir—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.019	0.0338	CbGbCtD
Saquinavir—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0181	0.0322	CbGbCtD
Saquinavir—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0169	0.0301	CbGbCtD
Saquinavir—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0166	0.0295	CbGbCtD
Saquinavir—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0164	0.0291	CbGbCtD
Saquinavir—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0153	0.0272	CbGbCtD
Saquinavir—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0153	0.0272	CbGbCtD
Saquinavir—ABCG2—Etoposide—peripheral nervous system neoplasm	0.015	0.0267	CbGbCtD
Saquinavir—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0139	0.0246	CbGbCtD
Saquinavir—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0139	0.0246	CbGbCtD
Saquinavir—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0133	0.0236	CbGbCtD
Saquinavir—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0121	0.0215	CbGbCtD
Saquinavir—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0121	0.0215	CbGbCtD
Saquinavir—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0113	0.0202	CbGbCtD
Saquinavir—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0102	0.0182	CbGbCtD
Saquinavir—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0096	0.0171	CbGbCtD
Saquinavir—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.00908	0.0161	CbGbCtD
Saquinavir—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00832	0.0148	CbGbCtD
Saquinavir—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0083	0.0148	CbGbCtD
Saquinavir—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.008	0.0142	CbGbCtD
Saquinavir—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00772	0.0137	CbGbCtD
Saquinavir—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00591	0.0105	CbGbCtD
Saquinavir—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00568	0.0101	CbGbCtD
Saquinavir—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00551	0.0098	CbGbCtD
Saquinavir—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00542	0.00963	CbGbCtD
Saquinavir—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0037	0.00657	CbGbCtD
Saquinavir—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00354	0.0063	CbGbCtD
Saquinavir—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00348	0.00619	CbGbCtD
Saquinavir—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00325	0.00577	CbGbCtD
Saquinavir—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00221	0.00394	CbGbCtD
Saquinavir—Atazanavir—ABCB1—peripheral nervous system neoplasm	0.000759	0.335	CrCbGaD
Saquinavir—Lopinavir—ABCB1—peripheral nervous system neoplasm	0.000541	0.239	CrCbGaD
Saquinavir—Nelfinavir—ABCB1—peripheral nervous system neoplasm	0.000503	0.222	CrCbGaD
Saquinavir—Indinavir—ABCB1—peripheral nervous system neoplasm	0.000461	0.204	CrCbGaD
Saquinavir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	4.78e-05	0.000207	CcSEcCtD
Saquinavir—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000206	CcSEcCtD
Saquinavir—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	4.74e-05	0.000205	CcSEcCtD
Saquinavir—Paraesthesia—Etoposide—peripheral nervous system neoplasm	4.74e-05	0.000205	CcSEcCtD
Saquinavir—Weight increased—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000205	CcSEcCtD
Saquinavir—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.000204	CcSEcCtD
Saquinavir—Weight decreased—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000204	CcSEcCtD
Saquinavir—Dyspnoea—Etoposide—peripheral nervous system neoplasm	4.7e-05	0.000204	CcSEcCtD
Saquinavir—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	4.69e-05	0.000203	CcSEcCtD
Saquinavir—Somnolence—Etoposide—peripheral nervous system neoplasm	4.69e-05	0.000203	CcSEcCtD
Saquinavir—Asthenia—Vincristine—peripheral nervous system neoplasm	4.67e-05	0.000202	CcSEcCtD
Saquinavir—Pneumonia—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000202	CcSEcCtD
Saquinavir—Infestation—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000201	CcSEcCtD
Saquinavir—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000201	CcSEcCtD
Saquinavir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	4.63e-05	0.000201	CcSEcCtD
Saquinavir—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.0002	CcSEcCtD
Saquinavir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	4.62e-05	0.0002	CcSEcCtD
Saquinavir—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000199	CcSEcCtD
Saquinavir—Rash—Dactinomycin—peripheral nervous system neoplasm	4.6e-05	0.000199	CcSEcCtD
Saquinavir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	4.59e-05	0.000199	CcSEcCtD
Saquinavir—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.000198	CcSEcCtD
Saquinavir—Renal failure—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000197	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	4.55e-05	0.000197	CcSEcCtD
Saquinavir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	4.55e-05	0.000197	CcSEcCtD
Saquinavir—Fatigue—Etoposide—peripheral nervous system neoplasm	4.55e-05	0.000197	CcSEcCtD
Saquinavir—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	4.54e-05	0.000197	CcSEcCtD
Saquinavir—Jaundice—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.000196	CcSEcCtD
Saquinavir—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.000196	CcSEcCtD
Saquinavir—Constipation—Etoposide—peripheral nervous system neoplasm	4.51e-05	0.000195	CcSEcCtD
Saquinavir—Pain—Etoposide—peripheral nervous system neoplasm	4.51e-05	0.000195	CcSEcCtD
Saquinavir—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000195	CcSEcCtD
Saquinavir—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000195	CcSEcCtD
Saquinavir—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000195	CcSEcCtD
Saquinavir—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000194	CcSEcCtD
Saquinavir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.47e-05	0.000194	CcSEcCtD
Saquinavir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.46e-05	0.000193	CcSEcCtD
Saquinavir—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.00019	CcSEcCtD
Saquinavir—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.38e-05	0.00019	CcSEcCtD
Saquinavir—Weight increased—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.00019	CcSEcCtD
Saquinavir—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000189	CcSEcCtD
Saquinavir—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000189	CcSEcCtD
Saquinavir—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000188	CcSEcCtD
Saquinavir—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.35e-05	0.000188	CcSEcCtD
Saquinavir—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.34e-05	0.000188	CcSEcCtD
Saquinavir—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.33e-05	0.000187	CcSEcCtD
Saquinavir—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000187	CcSEcCtD
Saquinavir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.31e-05	0.000187	CcSEcCtD
Saquinavir—Dizziness—Vincristine—peripheral nervous system neoplasm	4.31e-05	0.000186	CcSEcCtD
Saquinavir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.3e-05	0.000186	CcSEcCtD
Saquinavir—Infestation—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000186	CcSEcCtD
Saquinavir—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000186	CcSEcCtD
Saquinavir—Rash—Alitretinoin—peripheral nervous system neoplasm	4.26e-05	0.000185	CcSEcCtD
Saquinavir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.26e-05	0.000184	CcSEcCtD
Saquinavir—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000184	CcSEcCtD
Saquinavir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.24e-05	0.000184	CcSEcCtD
Saquinavir—Headache—Alitretinoin—peripheral nervous system neoplasm	4.23e-05	0.000183	CcSEcCtD
Saquinavir—Renal failure—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000183	CcSEcCtD
Saquinavir—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.2e-05	0.000182	CcSEcCtD
Saquinavir—Urticaria—Etoposide—peripheral nervous system neoplasm	4.19e-05	0.000181	CcSEcCtD
Saquinavir—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.000181	CcSEcCtD
Saquinavir—Jaundice—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000181	CcSEcCtD
Saquinavir—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000181	CcSEcCtD
Saquinavir—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.000181	CcSEcCtD
Saquinavir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.17e-05	0.000181	CcSEcCtD
Saquinavir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.17e-05	0.000181	CcSEcCtD
Saquinavir—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000181	CcSEcCtD
Saquinavir—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000181	CcSEcCtD
Saquinavir—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.00018	CcSEcCtD
Saquinavir—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.00018	CcSEcCtD
Saquinavir—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000179	CcSEcCtD
Saquinavir—Vomiting—Vincristine—peripheral nervous system neoplasm	4.14e-05	0.000179	CcSEcCtD
Saquinavir—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.13e-05	0.000179	CcSEcCtD
Saquinavir—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000179	CcSEcCtD
Saquinavir—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000178	CcSEcCtD
Saquinavir—Rash—Vincristine—peripheral nervous system neoplasm	4.11e-05	0.000178	CcSEcCtD
Saquinavir—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.1e-05	0.000178	CcSEcCtD
Saquinavir—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.000177	CcSEcCtD
Saquinavir—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.08e-05	0.000177	CcSEcCtD
Saquinavir—Headache—Vincristine—peripheral nervous system neoplasm	4.08e-05	0.000177	CcSEcCtD
Saquinavir—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000176	CcSEcCtD
Saquinavir—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000175	CcSEcCtD
Saquinavir—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000174	CcSEcCtD
Saquinavir—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.01e-05	0.000174	CcSEcCtD
Saquinavir—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000174	CcSEcCtD
Saquinavir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	3.94e-05	0.000171	CcSEcCtD
Saquinavir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.00017	CcSEcCtD
Saquinavir—Eye disorder—Epirubicin—peripheral nervous system neoplasm	3.89e-05	0.000168	CcSEcCtD
Saquinavir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	3.89e-05	0.000168	CcSEcCtD
Saquinavir—Tinnitus—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000168	CcSEcCtD
Saquinavir—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000168	CcSEcCtD
Saquinavir—Nausea—Vincristine—peripheral nervous system neoplasm	3.87e-05	0.000168	CcSEcCtD
Saquinavir—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	3.86e-05	0.000167	CcSEcCtD
Saquinavir—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000167	CcSEcCtD
Saquinavir—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000167	CcSEcCtD
Saquinavir—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000167	CcSEcCtD
Saquinavir—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000166	CcSEcCtD
Saquinavir—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000166	CcSEcCtD
Saquinavir—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000165	CcSEcCtD
Saquinavir—Asthenia—Etoposide—peripheral nervous system neoplasm	3.78e-05	0.000164	CcSEcCtD
Saquinavir—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000164	CcSEcCtD
Saquinavir—Angiopathy—Epirubicin—peripheral nervous system neoplasm	3.78e-05	0.000164	CcSEcCtD
Saquinavir—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	3.77e-05	0.000163	CcSEcCtD
Saquinavir—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.000163	CcSEcCtD
Saquinavir—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	3.75e-05	0.000162	CcSEcCtD
Saquinavir—Chills—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000162	CcSEcCtD
Saquinavir—Pruritus—Etoposide—peripheral nervous system neoplasm	3.73e-05	0.000162	CcSEcCtD
Saquinavir—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000161	CcSEcCtD
Saquinavir—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.68e-05	0.000159	CcSEcCtD
Saquinavir—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.66e-05	0.000159	CcSEcCtD
Saquinavir—Mental disorder—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.000158	CcSEcCtD
Saquinavir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	3.64e-05	0.000158	CcSEcCtD
Saquinavir—Rash—Cisplatin—peripheral nervous system neoplasm	3.63e-05	0.000157	CcSEcCtD
Saquinavir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.63e-05	0.000157	CcSEcCtD
Saquinavir—Erythema—Epirubicin—peripheral nervous system neoplasm	3.62e-05	0.000157	CcSEcCtD
Saquinavir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	3.62e-05	0.000157	CcSEcCtD
Saquinavir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.61e-05	0.000156	CcSEcCtD
Saquinavir—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.000156	CcSEcCtD
Saquinavir—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.000155	CcSEcCtD
Saquinavir—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000155	CcSEcCtD
Saquinavir—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.57e-05	0.000155	CcSEcCtD
Saquinavir—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.000154	CcSEcCtD
Saquinavir—Back pain—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.000152	CcSEcCtD
Saquinavir—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000151	CcSEcCtD
Saquinavir—Dizziness—Etoposide—peripheral nervous system neoplasm	3.49e-05	0.000151	CcSEcCtD
Saquinavir—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.48e-05	0.000151	CcSEcCtD
Saquinavir—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.000151	CcSEcCtD
Saquinavir—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.00015	CcSEcCtD
Saquinavir—Chills—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.00015	CcSEcCtD
Saquinavir—Nausea—Cisplatin—peripheral nervous system neoplasm	3.42e-05	0.000148	CcSEcCtD
Saquinavir—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.4e-05	0.000147	CcSEcCtD
Saquinavir—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.37e-05	0.000146	CcSEcCtD
Saquinavir—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000146	CcSEcCtD
Saquinavir—Vomiting—Etoposide—peripheral nervous system neoplasm	3.35e-05	0.000145	CcSEcCtD
Saquinavir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000145	CcSEcCtD
Saquinavir—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000145	CcSEcCtD
Saquinavir—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.35e-05	0.000145	CcSEcCtD
Saquinavir—Agitation—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000144	CcSEcCtD
Saquinavir—Rash—Etoposide—peripheral nervous system neoplasm	3.33e-05	0.000144	CcSEcCtD
Saquinavir—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.32e-05	0.000144	CcSEcCtD
Saquinavir—Headache—Etoposide—peripheral nervous system neoplasm	3.3e-05	0.000143	CcSEcCtD
Saquinavir—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000143	CcSEcCtD
Saquinavir—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.000142	CcSEcCtD
Saquinavir—Malaise—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000141	CcSEcCtD
Saquinavir—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.000141	CcSEcCtD
Saquinavir—Syncope—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.000141	CcSEcCtD
Saquinavir—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.24e-05	0.00014	CcSEcCtD
Saquinavir—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.00014	CcSEcCtD
Saquinavir—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.00014	CcSEcCtD
Saquinavir—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.18e-05	0.000138	CcSEcCtD
Saquinavir—Cough—Epirubicin—peripheral nervous system neoplasm	3.16e-05	0.000137	CcSEcCtD
Saquinavir—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000136	CcSEcCtD
Saquinavir—Nausea—Etoposide—peripheral nervous system neoplasm	3.13e-05	0.000136	CcSEcCtD
Saquinavir—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.13e-05	0.000135	CcSEcCtD
Saquinavir—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.000135	CcSEcCtD
Saquinavir—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.000134	CcSEcCtD
Saquinavir—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000134	CcSEcCtD
Saquinavir—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000134	CcSEcCtD
Saquinavir—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000134	CcSEcCtD
Saquinavir—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000133	CcSEcCtD
Saquinavir—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.07e-05	0.000133	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000133	CcSEcCtD
Saquinavir—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.05e-05	0.000132	CcSEcCtD
Saquinavir—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000131	CcSEcCtD
Saquinavir—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.02e-05	0.000131	CcSEcCtD
Saquinavir—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.01e-05	0.00013	CcSEcCtD
Saquinavir—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.01e-05	0.00013	CcSEcCtD
Saquinavir—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.00013	CcSEcCtD
Saquinavir—Confusional state—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000129	CcSEcCtD
Saquinavir—Oedema—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000128	CcSEcCtD
Saquinavir—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.000128	CcSEcCtD
Saquinavir—Infection—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.000127	CcSEcCtD
Saquinavir—Cough—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000127	CcSEcCtD
Saquinavir—Shock—Epirubicin—peripheral nervous system neoplasm	2.91e-05	0.000126	CcSEcCtD
Saquinavir—Convulsion—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000126	CcSEcCtD
Saquinavir—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.000126	CcSEcCtD
Saquinavir—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.89e-05	0.000125	CcSEcCtD
Saquinavir—Hypertension—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000125	CcSEcCtD
Saquinavir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	2.87e-05	0.000124	CcSEcCtD
Saquinavir—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.86e-05	0.000124	CcSEcCtD
Saquinavir—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000124	CcSEcCtD
Saquinavir—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000124	CcSEcCtD
Saquinavir—Chest pain—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000124	CcSEcCtD
Saquinavir—Anxiety—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.000123	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000123	CcSEcCtD
Saquinavir—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.82e-05	0.000122	CcSEcCtD
Saquinavir—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000122	CcSEcCtD
Saquinavir—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	2.79e-05	0.000121	CcSEcCtD
Saquinavir—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.76e-05	0.00012	CcSEcCtD
Saquinavir—Confusional state—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000119	CcSEcCtD
Saquinavir—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.000118	CcSEcCtD
Saquinavir—Infection—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000118	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.69e-05	0.000117	CcSEcCtD
Saquinavir—Shock—Doxorubicin—peripheral nervous system neoplasm	2.69e-05	0.000117	CcSEcCtD
Saquinavir—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000116	CcSEcCtD
Saquinavir—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000116	CcSEcCtD
Saquinavir—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.67e-05	0.000116	CcSEcCtD
Saquinavir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.66e-05	0.000115	CcSEcCtD
Saquinavir—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.65e-05	0.000115	CcSEcCtD
Saquinavir—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.64e-05	0.000115	CcSEcCtD
Saquinavir—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.64e-05	0.000114	CcSEcCtD
Saquinavir—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.63e-05	0.000114	CcSEcCtD
Saquinavir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000113	CcSEcCtD
Saquinavir—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000113	CcSEcCtD
Saquinavir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.57e-05	0.000111	CcSEcCtD
Saquinavir—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.56e-05	0.000111	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.55e-05	0.000111	CcSEcCtD
Saquinavir—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.55e-05	0.00011	CcSEcCtD
Saquinavir—Pain—Epirubicin—peripheral nervous system neoplasm	2.53e-05	0.00011	CcSEcCtD
Saquinavir—Constipation—Epirubicin—peripheral nervous system neoplasm	2.53e-05	0.00011	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000108	CcSEcCtD
Saquinavir—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.47e-05	0.000107	CcSEcCtD
Saquinavir—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.46e-05	0.000106	CcSEcCtD
Saquinavir—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.44e-05	0.000106	CcSEcCtD
Saquinavir—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.44e-05	0.000106	CcSEcCtD
Saquinavir—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.43e-05	0.000105	CcSEcCtD
Saquinavir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.42e-05	0.000105	CcSEcCtD
Saquinavir—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.41e-05	0.000104	CcSEcCtD
Saquinavir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	0.000103	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	0.000102	CcSEcCtD
Saquinavir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	0.000102	CcSEcCtD
Saquinavir—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.35e-05	0.000102	CcSEcCtD
Saquinavir—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.34e-05	0.000101	CcSEcCtD
Saquinavir—Pain—Doxorubicin—peripheral nervous system neoplasm	2.34e-05	0.000101	CcSEcCtD
Saquinavir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.34e-05	0.000101	CcSEcCtD
Saquinavir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.34e-05	0.000101	CcSEcCtD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.3e-05	0.00239	CbGpPWpGaD
Saquinavir—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.27e-05	0.00236	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.27e-05	0.00235	CbGpPWpGaD
Saquinavir—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.25e-05	9.76e-05	CcSEcCtD
Saquinavir—SLC22A1—Neuronal System—BCHE—peripheral nervous system neoplasm	2.25e-05	0.00233	CbGpPWpGaD
Saquinavir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.24e-05	9.69e-05	CcSEcCtD
Saquinavir—SLC22A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.18e-05	0.00226	CbGpPWpGaD
Saquinavir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.18e-05	9.43e-05	CcSEcCtD
Saquinavir—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.17e-05	9.41e-05	CcSEcCtD
Saquinavir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.16e-05	9.37e-05	CcSEcCtD
Saquinavir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.16e-05	9.37e-05	CcSEcCtD
Saquinavir—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.12e-05	9.19e-05	CcSEcCtD
Saquinavir—CYP11A1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	2.11e-05	0.00219	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.09e-05	0.00217	CbGpPWpGaD
Saquinavir—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.09e-05	9.06e-05	CcSEcCtD
Saquinavir—CYP11A1—Metabolism—GNS—peripheral nervous system neoplasm	2.07e-05	0.00215	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.06e-05	0.00214	CbGpPWpGaD
Saquinavir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.02e-05	8.76e-05	CcSEcCtD
Saquinavir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.02e-05	8.73e-05	CcSEcCtD
Saquinavir—CYP11A1—Metabolism—NME1—peripheral nervous system neoplasm	1.98e-05	0.00206	CbGpPWpGaD
Saquinavir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.96e-05	8.5e-05	CcSEcCtD
Saquinavir—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.96e-05	8.47e-05	CcSEcCtD
Saquinavir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.94e-05	8.38e-05	CcSEcCtD
Saquinavir—CYP11A1—Metabolism—COX2—peripheral nervous system neoplasm	1.91e-05	0.00198	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.89e-05	0.00196	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.88e-05	0.00195	CbGpPWpGaD
Saquinavir—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.88e-05	8.14e-05	CcSEcCtD
Saquinavir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.87e-05	8.11e-05	CcSEcCtD
Saquinavir—Rash—Epirubicin—peripheral nervous system neoplasm	1.86e-05	8.07e-05	CcSEcCtD
Saquinavir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.86e-05	8.07e-05	CcSEcCtD
Saquinavir—Headache—Epirubicin—peripheral nervous system neoplasm	1.85e-05	8.02e-05	CcSEcCtD
Saquinavir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.81e-05	7.84e-05	CcSEcCtD
Saquinavir—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.79e-05	0.00186	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.76e-05	0.00183	CbGpPWpGaD
Saquinavir—Nausea—Epirubicin—peripheral nervous system neoplasm	1.76e-05	7.61e-05	CcSEcCtD
Saquinavir—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.74e-05	0.00181	CbGpPWpGaD
Saquinavir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	7.53e-05	CcSEcCtD
Saquinavir—Rash—Doxorubicin—peripheral nervous system neoplasm	1.72e-05	7.47e-05	CcSEcCtD
Saquinavir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.72e-05	7.46e-05	CcSEcCtD
Saquinavir—Headache—Doxorubicin—peripheral nervous system neoplasm	1.71e-05	7.42e-05	CcSEcCtD
Saquinavir—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.66e-05	0.00172	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.64e-05	0.00171	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.64e-05	0.0017	CbGpPWpGaD
Saquinavir—ABCC1—Disease—GNS—peripheral nervous system neoplasm	1.63e-05	0.00169	CbGpPWpGaD
Saquinavir—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.62e-05	7.04e-05	CcSEcCtD
Saquinavir—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.6e-05	0.00166	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	1.59e-05	0.00165	CbGpPWpGaD
Saquinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.58e-05	0.00164	CbGpPWpGaD
Saquinavir—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.58e-05	0.00164	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.57e-05	0.00163	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.53e-05	0.00159	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.52e-05	0.00158	CbGpPWpGaD
Saquinavir—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.52e-05	0.00158	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.52e-05	0.00157	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.51e-05	0.00157	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.49e-05	0.00155	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.49e-05	0.00155	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.46e-05	0.00151	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.45e-05	0.00151	CbGpPWpGaD
Saquinavir—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.44e-05	0.00149	CbGpPWpGaD
Saquinavir—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.42e-05	0.00148	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.4e-05	0.00145	CbGpPWpGaD
Saquinavir—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.38e-05	0.00144	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.37e-05	0.00142	CbGpPWpGaD
Saquinavir—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	1.37e-05	0.00142	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	1.36e-05	0.00141	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.36e-05	0.00141	CbGpPWpGaD
Saquinavir—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.35e-05	0.0014	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.33e-05	0.00138	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	1.33e-05	0.00138	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	1.31e-05	0.00136	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	1.3e-05	0.00134	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.28e-05	0.00133	CbGpPWpGaD
Saquinavir—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.27e-05	0.00132	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	1.26e-05	0.00131	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.25e-05	0.0013	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.25e-05	0.0013	CbGpPWpGaD
Saquinavir—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.25e-05	0.0013	CbGpPWpGaD
Saquinavir—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.25e-05	0.00129	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	1.24e-05	0.00129	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.24e-05	0.00129	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	1.2e-05	0.00125	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	1.2e-05	0.00124	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	1.19e-05	0.00123	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.19e-05	0.00123	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	1.17e-05	0.00121	CbGpPWpGaD
Saquinavir—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.16e-05	0.0012	CbGpPWpGaD
Saquinavir—SLC22A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.15e-05	0.0012	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.15e-05	0.00119	CbGpPWpGaD
Saquinavir—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.14e-05	0.00119	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	1.14e-05	0.00118	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	1.14e-05	0.00118	CbGpPWpGaD
Saquinavir—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.14e-05	0.00118	CbGpPWpGaD
Saquinavir—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.12e-05	0.00116	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.11e-05	0.00115	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—GNS—peripheral nervous system neoplasm	1.11e-05	0.00115	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	1.1e-05	0.00114	CbGpPWpGaD
Saquinavir—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.09e-05	0.00113	CbGpPWpGaD
Saquinavir—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.07e-05	0.00111	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—NME1—peripheral nervous system neoplasm	1.06e-05	0.0011	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.06e-05	0.0011	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.03e-05	0.00107	CbGpPWpGaD
Saquinavir—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.02e-05	0.00106	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—COX2—peripheral nervous system neoplasm	1.02e-05	0.00106	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.01e-05	0.00105	CbGpPWpGaD
Saquinavir—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.01e-05	0.00104	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—TH—peripheral nervous system neoplasm	9.95e-06	0.00103	CbGpPWpGaD
Saquinavir—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.87e-06	0.00102	CbGpPWpGaD
Saquinavir—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	9.86e-06	0.00102	CbGpPWpGaD
Saquinavir—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.28e-06	0.000963	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.19e-06	0.000954	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	9.18e-06	0.000953	CbGpPWpGaD
Saquinavir—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.11e-06	0.000945	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.97e-06	0.000931	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	8.85e-06	0.000919	CbGpPWpGaD
Saquinavir—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	8.65e-06	0.000898	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	8.59e-06	0.000892	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.56e-06	0.000888	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.51e-06	0.000883	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.45e-06	0.000877	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.38e-06	0.00087	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	8.26e-06	0.000857	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	8.24e-06	0.000855	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	8.2e-06	0.000851	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.18e-06	0.000849	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—GNAS—peripheral nervous system neoplasm	8.12e-06	0.000843	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.97e-06	0.000827	CbGpPWpGaD
Saquinavir—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	7.95e-06	0.000825	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	7.93e-06	0.000823	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	7.85e-06	0.000815	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	7.75e-06	0.000805	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.72e-06	0.000801	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.64e-06	0.000793	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	7.52e-06	0.000781	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	7.44e-06	0.000773	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GNS—peripheral nervous system neoplasm	7.4e-06	0.000768	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.4e-06	0.000768	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	7.29e-06	0.000757	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	7.27e-06	0.000754	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	7.2e-06	0.000748	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	7.17e-06	0.000745	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	7.14e-06	0.000741	CbGpPWpGaD
Saquinavir—ALB—Metabolism—NME1—peripheral nervous system neoplasm	7.09e-06	0.000737	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	6.98e-06	0.000724	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.96e-06	0.000723	CbGpPWpGaD
Saquinavir—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.89e-06	0.000715	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	6.87e-06	0.000713	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	6.83e-06	0.000709	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	6.83e-06	0.000709	CbGpPWpGaD
Saquinavir—ALB—Metabolism—COX2—peripheral nervous system neoplasm	6.83e-06	0.000709	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.76e-06	0.000702	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	6.7e-06	0.000696	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.66e-06	0.000691	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	6.64e-06	0.00069	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	6.63e-06	0.000688	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	6.56e-06	0.000681	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	6.48e-06	0.000673	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	6.37e-06	0.000661	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.33e-06	0.000657	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	6.23e-06	0.000647	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	6.22e-06	0.000645	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.21e-06	0.000644	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	6.14e-06	0.000637	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	6.13e-06	0.000636	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	6.11e-06	0.000634	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.09e-06	0.000632	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	6.09e-06	0.000632	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	6.06e-06	0.000629	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	5.98e-06	0.000621	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	5.95e-06	0.000618	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	5.86e-06	0.000608	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.86e-06	0.000608	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	5.84e-06	0.000606	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	5.81e-06	0.000603	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.81e-06	0.000603	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	5.77e-06	0.000599	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	5.72e-06	0.000594	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	5.66e-06	0.000588	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	5.64e-06	0.000585	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	5.59e-06	0.00058	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.53e-06	0.000574	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.44e-06	0.000565	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.4e-06	0.000561	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	5.36e-06	0.000556	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.33e-06	0.000554	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	5.32e-06	0.000553	CbGpPWpGaD
Saquinavir—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	5.28e-06	0.000548	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.26e-06	0.000546	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	5.21e-06	0.00054	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	5.09e-06	0.000528	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.99e-06	0.000518	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	4.98e-06	0.000517	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	4.71e-06	0.000489	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	4.67e-06	0.000485	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.62e-06	0.00048	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	4.58e-06	0.000476	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	4.51e-06	0.000468	CbGpPWpGaD
Saquinavir—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	4.48e-06	0.000465	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	4.44e-06	0.000461	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	4.4e-06	0.000457	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.38e-06	0.000455	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	4.35e-06	0.000451	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.27e-06	0.000443	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.2e-06	0.000436	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	4.14e-06	0.000429	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	4.02e-06	0.000418	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.99e-06	0.000415	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	3.93e-06	0.000408	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.83e-06	0.000398	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	3.81e-06	0.000396	CbGpPWpGaD
Saquinavir—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	3.79e-06	0.000393	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	3.76e-06	0.00039	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	3.7e-06	0.000384	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.7e-06	0.000384	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.69e-06	0.000383	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	3.67e-06	0.000381	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.63e-06	0.000377	CbGpPWpGaD
Saquinavir—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.61e-06	0.000375	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	3.58e-06	0.000372	CbGpPWpGaD
Saquinavir—ALB—Metabolism—TH—peripheral nervous system neoplasm	3.56e-06	0.00037	CbGpPWpGaD
Saquinavir—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	3.51e-06	0.000365	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	3.4e-06	0.000353	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	3.38e-06	0.000351	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	3.32e-06	0.000345	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	3.31e-06	0.000344	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.24e-06	0.000337	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	3.2e-06	0.000332	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.17e-06	0.000329	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	3.13e-06	0.000325	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	3.12e-06	0.000324	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	3.1e-06	0.000322	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	3e-06	0.000311	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.98e-06	0.00031	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.96e-06	0.000307	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	2.94e-06	0.000305	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	2.92e-06	0.000304	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	2.92e-06	0.000303	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	2.91e-06	0.000302	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	2.87e-06	0.000298	CbGpPWpGaD
Saquinavir—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	2.85e-06	0.000296	CbGpPWpGaD
Saquinavir—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	2.67e-06	0.000277	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	2.61e-06	0.000271	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	2.56e-06	0.000266	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	2.55e-06	0.000264	CbGpPWpGaD
Saquinavir—ABCC1—Disease—MYC—peripheral nervous system neoplasm	2.49e-06	0.000258	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.42e-06	0.000251	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	2.4e-06	0.000249	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	2.38e-06	0.000247	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.36e-06	0.000245	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	2.34e-06	0.000242	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	2.29e-06	0.000238	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	2.19e-06	0.000228	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.19e-06	0.000228	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.05e-06	0.000212	CbGpPWpGaD
Saquinavir—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	1.95e-06	0.000203	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.95e-06	0.000203	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	1.94e-06	0.000201	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.92e-06	0.0002	CbGpPWpGaD
Saquinavir—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	1.73e-06	0.000179	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.61e-06	0.000167	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.57e-06	0.000163	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.54e-06	0.00016	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	1.45e-06	0.00015	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	1.37e-06	0.000143	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	1.27e-06	0.000132	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	1.26e-06	0.000131	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.17e-06	0.000122	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	9.11e-07	9.46e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	7.89e-07	8.19e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	7.85e-07	8.15e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	7.05e-07	7.31e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	6.88e-07	7.14e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	6.48e-07	6.73e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	6.42e-07	6.67e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	4.24e-07	4.4e-05	CbGpPWpGaD
